Item 1.01. Entry into a Material Definitive Agreement.

On December 17, 2021, Clarus Therapeutics Holdings, Inc.'s wholly-owned subsidiary, Clarus Therapeutics, Inc. ("CTI") entered into the Ninth Amendment (the "Amendment") to the Office Lease dated August 18, 2011, by and between CTI and MJH Northbrook LLC, as amended (the "Lease") for the property located at 555 Skokie Boulevard, Northbrook, Illinois 60062. The Amendment extends the term of the Lease from December 31, 2021 to December 31, 2022.

Beginning on January 1, 2022, the CTI will pay rent at a rate of $6,149.33 per month. Except as amended by the Amendment, the Lease remains in full force and effect.

The foregoing description of the Amendment does not purport to be complete and is qualified in its entirety by reference to the complete text of the Amendment filed as Exhibit 10.1 to this Current Report on Form 8-K and incorporated by reference herein.

Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

The disclosure set forth in Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits:





10.1      Ninth Amendment to Office Lease dated as of December 17, 2021, by and
        between Clarus Therapeutics, Inc. and MJH Northbrook LLC. (incorporated by
        reference to Exhibit 10.13 to the Registration Statement on Form S-1
        (333-261743) filed with the Securities and Exchange Commission on
        December 17, 2021).

104     Cover Page Interactive Data File (embedded within the Inline XBRL
        document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses